Anurag Jindal

Anurag Jindal, M.D. is a Senior Managing Director in the BioPharma Investment Banking division at SVB Securities (formerly SVB Leerink).1 He joined the firm in May 2021 to expand their biopharma investment banking franchise.1

Key points about Dr. Jindal's background and role:

Professional Experience

• Currently leads the BioPharma Investment Banking division at SVB Securities since 2020
• Previously worked as a Managing Director in the Healthcare Investment Banking group at Bank of America, focusing on strategic advisory and capital markets transactions for biotech companies1
• Held positions as Deputy Head of Pharma M&A and in the Pharma Strategy Group at Novartis in Switzerland1
• Worked in the Healthcare Investment Banking group at JP Morgan in New York and San Francisco1
• Started his career as a Pharmaceutical Analyst at Health IQ in Los Angeles1

Education

• Bachelor of Arts in Molecular and Cell Biology from the University of California, Berkeley1
• M.D. from the University of Southern California1

Role at SVB Securities

Dr. Jindal's hire was part of SVB Leerink's (now SVB Securities) strategy to reinforce its leadership in the biopharma and life sciences sector.1 His responsibilities include:

• Advising biopharma companies on navigating industry challenges
• Assisting with financing innovation
• Executing strategic transactions1

Dr. Jindal brings nearly two decades of experience in the biopharma industry, combining expertise as an investment banker, consultant, and executive at a major pharmaceutical company.1